Table 3.
Triacylglycerol (TG), Total Cholesterol (TC), High Density Lipoprotein - Cholesterol (HDL- C), insulin, adiponectin, adiponectin /sum of adipose tissue (SAT) concentrations during two treatment periods (30 days our 60 days) in the experimental groups
| Parameters | 30 Days of Treatment (n = 5-7 per group) | 60 Days of Treatment (n = 11-13 per group) | ||||||
|---|---|---|---|---|---|---|---|---|
| N S | NE | HFS | HFE | N S | NE | HFS | HFE | |
| TG (mg/dL) | 169.8 ± 19.1 | 166.8 ± 9.9 | 152.0 ± 8.5 | 137.6 ± 5.3 | 174.0 ± 16.1 | 184.0 ± 14.4 | 145.1 ± 5.4 | 136.6 ± 5.4** |
| TC (mg/dL) | 174.7 ± 7.5 | 176.5 ± 5.0 | 155.7 ± 7.5* | 181.6 ± 6.5$ | 176.7 ± 6.4 | 212.0 ± 11.4 | 194.9 ± 13.6 | 178.1 ± 8.6 |
| HDL-C (mg/dL) | 36.21 ± 2.2 | 40.99 ± 4.8 | 39.32 ± 4.5 | 36.89 ± 1.9 | 42.1 ± 1.3 | 44.4 ± 0.8 | 37.0 ± 1.0* | 42.6 ± 1.7$ |
| Insulin (ng/mL) | 0.6 ± 0.1 | 0.5 ± 0.1 | 0.3 ± 0.04 | 0.4 ± 0.05 | 1.2 ± 0.2 | 1.0 ± 0.3 | 1.9 ± 0.2 | 0.8 ± 0.1$ |
| Adiponectin (μg/mL) | - | - | - | - | 3.4 ± 0.2 | 2.5 ± 0.2* | 1.8 ± 0.2* | 1.6 ± 0.1** |
| Adiponectin/SAT | - | - | - | - | 99.8 ± 14.8 | 91.6 ± 8.6 | 30.1 ± 5.4* | 33.9 ± 5.2$ |
Data are mean ± SEM (n = 5-8 per group); *Different from NS. **Different from NE. $Different from HFS.